Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy (Q44525923)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2003
edit
Language Label Description Also known as
English
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
scientific article published in August 2003

    Statements

    Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy (English)
    P Reichardt
    G Von Minckwitz
    P C Thuss-Patience
    F Jänicke
    D G Kieback
    A E Schindler
    S Mohrmann
    M Kaufmann
    H J Lück
    1 August 2003
    1227-1233

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit